loadpatents
Patent applications and USPTO patent grants for Bisserier; Malik.The latest application filed is for "tetrahydroquinoline derivatives and their use as epac inhibitors".
Patent | Date |
---|---|
Tetrahydroquinoline derivatives and their use as Epac inhibitors Grant 10,093,627 - Lezoualc'h , et al. October 9, 2 | 2018-10-09 |
Tetrahydroquinoline Derivatives and Their Use as Epac Inhibitors App 20180009757 - Lezoualc'h; Frank ;   et al. | 2018-01-11 |
Tetrahydroquinoline derivatives and their use as Epac inhibitors Grant 9,751,838 - Lezoualc'h , et al. September 5, 2 | 2017-09-05 |
Tetrahydroquinoline Derivatives And Their Use As Epac1 Inhibitors For The Treatment Of Myocardial Infarction Injury App 20170079970 - LEZOUALC'H; Frank ;   et al. | 2017-03-23 |
Tetrahydroquinoline Derivatives And Their Use As Epac Inhibitors App 20150252002 - Lezoualc'h; Frank ;   et al. | 2015-09-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.